Oncopeptides is a Swedish biotech company focusing on research, development and commercialization of targeted therapies for difficult-to-treat cancers.
The company uses its proprietary Peptide Drug Conjugate platform (PDC) to develop compounds that rapidly and selectively deliver cytotoxic agents into cancer cells. Its flagship drug, Pepaxti, is currently being commercialized in Europe with partnership agreements for South Korea, the Middle East and Africa and elsewhere.
Oncopeptides is also developing several new compounds based on its two proprietary technology platforms PDC and SPiKE.
The company was founded in 2000, has about 80 employees with operations in Sweden, Germany, Austria, Spain and Italy. Oncopeptides is listed on Nasdaq Stockholm with the ticker ONCO. For more information, visit: www.oncopeptides.com
Company Details
- Employees
- 83
- Founded
- -
- Address
- Luntmakargatan 46, Stockholm,11137,sweden
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- oncopeptides.com
- Keywords
- Multiple Myeloma, Plasma Cell Myeloma, Orphan Drug, Relapsed & Relapsed-Refractory Multiple Myeloma, anti-angiogenic, cytotoxicity, alkylation, peptidase targeting, efficacy studies, oncology, peptide conjugated alkylator, phase 1, phase 3, melflufen, RRMM, peptide-drug conjugate, melphalan flufenamide, phase 2, EMD.
- HQ
- Stockholm
Oncopeptides Ab (Publ) Questions
Oncopeptides Ab (Publ)'s website is oncopeptides.com
Oncopeptides Ab (Publ)'s LinkedIn profile is https://se.linkedin.com/company/oncopeptides
Oncopeptides Ab (Publ) has
83 employees.
View email and phone details for 83
employees at Oncopeptides Ab (Publ).
Oncopeptides Ab (Publ)'s industry is
Pharmaceutical Manufacturing
Oncopeptides Ab (Publ)'s top competitors are
Sprint Bioscience,
Alzecure Pharma,
Pelago Bioscience Ab,
Pharma Point,
Affibody Ab,
Xbrane Biopharma Ab,
Medivir Ab,
Bioarctic,
Biolamina,
Calliditas Therapeutics.
Oncopeptides Ab (Publ)'s categories are Pharmaceutical Manufacturing
Oncopeptides Ab (Publ)'s founding year is 2000
